Overview of new anticancer drugs of interest in Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D005467:Floxuridine / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007564:Japan
D000970:Antineoplastic Agents; D007093:Imidazoles; D005467:Floxuridine; C028138:5-carbamoyl-1H-imidazol-4-yl-piperonylate; D004317:Doxorubicin; C027260:pirarubicin; C025034:doxifluridine